BioSpace News Archive

Drug Development

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Blue Water Biotech, Inc today announced preliminary preclinical data supporting the use of its norovirus shell and protrusion (“S&P”) virus-like particle (“VLP”) platform to develop a novel monkeypox vaccine candidate.

June 28, 2023
·
6 min read
Lone Star Bio

Taysha Gene Therapies Provides Clinical Updates for Investigational Programs TSHA-120 in Giant Axonal Neuropathy (GAN) and TSHA-102 in Rett Syndrome at R&D Day

Taysha Gene Therapies, Inc. announced new data analyses for TSHA-120 in GAN and initial clinical observations for TSHA-102 in Rett syndrome.

June 28, 2023
·
9 min read
Business

Evommune Adds Additional Investment In Series B Financing And Bolsters Leadership Team

Evommune, Inc. today announced the closing of an additional $7.5 million to its Series B financing from new investor Verition Fund Management, bringing the total raised in the Series B round to $57.5 million.

June 28, 2023
·
2 min read
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development

Recently, Sanyou Biopharmaceuticals Co., Ltd. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co., Ltd., signed a license agreement for a collaboratively developed therapeutic biological product.

June 28, 2023
·
4 min read
Pharm Country

DiamiR Biosciences Announces Publication of Analytical Validation Data for its microRNA Testing Platform

DiamiR Biosciences today announced that the data related to analytical validation of the company’s 24 microRNA panel for risk assessment of Alzheimer’s disease, CogniMIR.

June 28, 2023
·
2 min read
BioForest

OtoNexus Medical Technologies Honored as a Top 100 Best Place to Work in Washington State

OtoNexus Medical Technologies, a medical device innovator, is celebrating its recognition as one of Washington’s 100 Best Workplaces.

June 28, 2023
·
2 min read
Deals

Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market

Minerva Neurosciences, Inc. today announced that it has agreed to sell an aggregate of 1,425,000 shares of its common stock at a purchase price of $10 per share and pre-funded warrants to purchase an aggregate of 575,575 shares of its common stock at a purchase price of $9.99 per pre-funded warrant.

June 28, 2023
·
4 min read
Drug Development

Verona Pharma Announces Publication of Phase 3 ENHANCE Data in the American Journal of Respiratory and Critical Care Medicine

Verona Pharma plc, announces the American Journal of Respiratory and Critical Care Medicine has published results from its Phase 3 ENHANCE trials evaluating ensifentrine in chronic obstructive pulmonary disease.

June 28, 2023
·
9 min read
Press Releases

Caeregen Therapeutics and Wacker Biotech Announce Collaboration Agreement to Produce the Regenerative Medicine Clinical Candidate CTR-107 (Noregen™) for Retinal Diseases

Caeregen Therapeutics, a regenerative medicine therapeutics company and Wacker Biotech, a contract development and manufacturing organization, will collaborate on the development and production of CTR-107, a novel regenerative therapeutic for the treatment of retinal-related vision loss.

June 28, 2023
·
6 min read
Business

Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla

Kineta, Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced the appointment of Kim Drapkin and Scott Dylla, Ph.D. to its Board of Directors.

June 28, 2023
·
6 min read